Mean change in BMD of the lumbar spine · postmenopausal women with osteoporosis and CKD stages 3‐4
1 finding from 1 review
Total hip BMD · postmenopausal women with osteoporosis and CKD stages 3‐4
1 finding from 1 review
Mean change in BMD of the distal radius · postmenopausal women with osteoporosis and CKD stages 3‐4
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · postmenopausal women with osteoporosis and CKD stages 3‐4
Any anti‐osteoporotic drugs showed no clear difference in adverse events compared with placebo (moderate certainty).
1 finding from 1 review
Death · postmenopausal women with osteoporosis and CKD stages 3‐4
1 finding from 1 review
QoL · postmenopausal women with osteoporosis and CKD stages 3‐4
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Stuttering frequency (% SS) · children aged six years and younger who stutter
1 finding from 1 review
Stuttering severity · children aged six years and younger who stutter
1 finding from 1 review
Speech efficiency (syllables per second) · children aged six years and younger who stutter
1 finding from 1 review
Communication attitudes · children aged six years and younger who stutter
1 finding from 1 review
Adverse effects · children aged six years and younger who stutter
1 finding from 1 review
Pruritus · pregnant women with intrahepatic cholestasis
1 finding from 1 review
Stillbirth · pregnant women with intrahepatic cholestasis
It is very uncertain whether ursodeoxycholic acid (UDCA) changes stillbirth compared with placebo (very low certainty).
1 finding from 1 review
Fetal distress/asphyxial events · pregnant women with intrahepatic cholestasis
It is very uncertain whether ursodeoxycholic acid (UDCA) changes fetal distress/asphyxial events compared with placebo (very low certainty).
1 finding from 1 review
Depression: mean scores at end of treatment (Analysis 1.4) · people with stroke
1 finding from 1 review
Psychological distress post‐treatment · people with stroke
1 finding from 1 review
General health · people with stroke
1 finding from 1 review
Social activities: mean scores at end of treatment (Analysis 2.10) · people with stroke
1 finding from 1 review
Activities of daily living · people with stroke
1 finding from 1 review
Adverse events: death ‐ at end of treatment (Analysis 1.14) · people with stroke
It is very uncertain whether psychological therapy changes adverse events: death ‐ at end of treatment (Analysis 2.16) compared with usual care and/or attention control (very low certainty).
1 finding from 1 review